Protein Description

Gene Symbol CRP
Entrez ID 1401
Uniprot ID P02741
Description C-reactive protein, pentraxin-related
Chromosomal Location chr1: 159,712,289-159,714,589
Ontology GO ID GO Term Definition Evidence

BP

GO:0006953

acute-phase response

An acute inflammatory response that involves non-antibody proteins whose concentrations in the plasma increase in response to infection or injury of homeothermic animals.

TAS

BP

GO:0006954

inflammatory response

The immediate defensive reaction (by vertebrate tissue) to infection or injury caused by chemical or physical agents. The process is characterized by local vasodilation, extravasation of plasma into intercellular spaces and accumulation of white blood cells and macrophages.

TAS

BP

GO:0008228

opsonization

The process in which a microorganism (or other particulate material) is rendered more susceptible to phagocytosis by coating with an opsonin, a blood serum protein such as a complement component or antibody.

TAS

BP

GO:0010628

positive regulation of gene expression

Any process that increases the frequency, rate or extent of gene expression. Gene expression is the process in which a gene's coding sequence is converted into a mature gene product or products (proteins or RNA). This includes the production of an RNA transcript as well as any processing to produce a mature RNA product or an mRNA (for protein-coding genes) and the translation of that mRNA into protein. Protein maturation is included when required to form an active form of a product from an inactive precursor form.

IDA

BP

GO:0010745

negative regulation of macrophage derived foam cell differentiation

Any process that decreases the rate, frequency or extent of macrophage derived foam cell differentiation. Macrophage derived foam cell differentiation is the process in which a macrophage acquires the specialized features of a foam cell. A foam cell is a type of cell containing lipids in small vacuoles and typically seen in atherosclerotic lesions, as well as other conditions.

IDA

BP

GO:0010888

negative regulation of lipid storage

Any process that modulates the rate, frequency or extent of lipid storage. Lipid storage is the accumulation and maintenance in cells or tissues of lipids, compounds soluble in organic solvents but insoluble or sparingly soluble in aqueous solvents. Lipid reserves can be accumulated during early developmental stages for mobilization and utilization at later stages of development.

IDA

BP

GO:0032930

positive regulation of superoxide anion generation

Any process that activates or increases the frequency, rate or extent of enzymatic generation of superoxide by a cell.

IDA

BP

GO:0045908

negative regulation of vasodilation

Any process that stops, prevents, or reduces the frequency, rate or extent of vasodilation.

IDA|IMP

BP

GO:0050830

defense response to Gram-positive bacterium

Reactions triggered in response to the presence of a Gram-positive bacterium that act to protect the cell or organism.

TAS

BP

GO:2000482

regulation of interleukin-8 secretion

Any process that modulates the frequency, rate or extent of interleukin-8 secretion.

IDA

CC

GO:0005576

extracellular region

The space external to the outermost structure of a cell. For cells without external protective or external encapsulating structures this refers to space outside of the plasma membrane. This term covers the host cell environment outside an intracellular parasite.

NAS

CC

GO:0005615

extracellular space

That part of a multicellular organism outside the cells proper, usually taken to be outside the plasma membranes, and occupied by fluid.

IDA

CC

GO:0070062

extracellular exosome

A membrane-bounded vesicle that is released into the extracellular region by fusion of the limiting endosomal membrane of a multivesicular body with the plasma membrane. Extracellular exosomes, also simply called exosomes, have a diameter of about 40-100 nm.

IDA

MF

GO:0001849

complement component C1q binding

Interacting selectively and non-covalently with the C1q component of the classical complement cascade.

IDA

MF

GO:0005509

calcium ion binding

Interacting selectively and non-covalently with calcium ions (Ca2+).

IDA

MF

GO:0005515

protein binding

Interacting selectively and non-covalently with any protein or protein complex (a complex of two or more proteins that may include other nonprotein molecules).

IPI

MF

GO:0030169

low-density lipoprotein particle binding

Interacting selectively and non-covalently with a low-density lipoprotein particle, a lipoprotein particle that is rich in cholesterol esters and low in triglycerides, is typically composed of APOB100 and APOE, and has a density of 1.02-1.06 g/ml and a diameter of between 20-25 nm.

IDA

MF

GO:0033265

choline binding

Interacting selectively and non-covalently with choline, the amine 2-hydroxy-N,N,N-trimethylethanaminium.

TAS

MF

GO:0050750

low-density lipoprotein particle receptor binding

Interacting selectively and non-covalently with a low-density lipoprotein receptor.

IPI

Domain ID Description

IPR001759

Pentraxin-related

IPR013320

Concanavalin A-like lectin/glucanase domain

IPR030476

Pentaxin, conserved site

Pathway ID Pathway Term Pathway Source

WP1533

Vitamin B12 Metabolism

WikiPathways

WP15

Selenium Micronutrient Network

WikiPathways

WP3287

Overview of nanoparticle effects

WikiPathways

WP176

Folate Metabolism

WikiPathways

WP364

IL-6 signaling pathway

WikiPathways

UMLS CUI UMLS Term

C0003469

Anxiety Disorders

C0003873

Rheumatoid Arthritis

C0004153

Atherosclerosis

C0007222

Cardiovascular Diseases

C0010346

Crohn Disease

C0011854

Diabetes Mellitus, Insulin-Dependent

C0011884

Diabetic Retinopathy

C0018799

Heart Diseases

C0018801

Heart Failure

C0020503

Hyperparathyroidism, Secondary

C0020538

Hypertensive Disease

C0020557

Hypertriglyceridemia

C0021368

Inflammation

C0022661

Kidney Failure, Chronic

C0023281

Leishmaniasis

C0023290

Leishmaniasis, Visceral

C0024121

Lung Neoplasms

C0024141

Lupus Erythematosus, Systemic

C0024530

Malaria

C0025289

Meningitis

C0025517

Metabolic Diseases

C0027059

Myocarditis

C0027707

Nephritis, Interstitial

C0028754

Obesity

C0031099

Periodontitis

C0033860

Psoriasis

C0038587

Substance Withdrawal Syndrome

C0040053

Thrombosis

C0085397

Pasteurellaceae Infections

C0151744

Myocardial Ischemia

C0311375

Arsenic Poisoning

C0524620

Metabolic Syndrome X

C0948089

Acute Coronary Syndrome

C0993582

Arthritis, Experimental

C1956346

Coronary Artery Disease

C2239176

Liver Carcinoma

C3714514

Infection

Tissue Cell Type

liver

hepatocytes

Database Name

DisGeNET

DISEASES

DGA

No sources found.

Gene Symbol Entrez ID Uniprot ID Score

FCN2

2220

Q15485

0.56

HIST2H2AC

8338

Q16777

0.56

CRP

1401

P02741

0.62

MAPK3

5595

P27361

0.63

DGCR14

8220

Q96DF8

0.63

RPL13A

23521

P40429

0.63

MAPK8IP2

23542

Q13387

0.63

GMPPA

29926

Q96IJ6

0.63

C1QA

712

P02745

0.75

APCS

325

P02743

0.85

FCGR1A

2209

P12314

0.52

FCGR2B

2213

P31994

0.52

GP6

51206

Q9HCN6

0.52

LEP

3952

P41159

0.55

HIST1H2AG; HIST1H2AI; HIST1H2AK; HIST1H2AL; HIST1H2AM

8329

P0C0S8

0.55

HIST1H1A

3024

Q02539

0.59

GLUD1

2746

P00367

0.63

MAPK1

5594

P28482

0.63

FCGR2C

9103

P31995

0.63

LAMC3

10319

Q9Y6N6

0.63

SNRNP70

6625

P08621

0.73

FCGR2A

2212

P12318

0.75

FN1

2335

P02751

0.75

CFH

3075

P08603

0.76